Cargando…
Integration of metabolic activation with a predictive toxicogenomics signature to classify genotoxic versus nongenotoxic chemicals in human TK6 cells
The use of integrated approaches in genetic toxicology, including the incorporation of gene expression data to determine the molecular pathways involved in the response, is becoming more common. In a companion article, a genomic biomarker was developed in human TK6 cells to classify chemicals as gen...
Autores principales: | Buick, Julie K., Moffat, Ivy, Williams, Andrew, Swartz, Carol D., Recio, Leslie, Hyduke, Daniel R., Li, Heng‐Hong, Fornace, Albert J., Aubrecht, Jiri, Yauk, Carole L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506226/ https://www.ncbi.nlm.nih.gov/pubmed/25733247 http://dx.doi.org/10.1002/em.21940 |
Ejemplares similares
-
A predictive toxicogenomics signature to classify genotoxic versus non-genotoxic chemicals in human TK6 cells
por: Williams, Andrew, et al.
Publicado: (2015) -
Application of the TGx‐28.65 transcriptomic biomarker to classify genotoxic and non‐genotoxic chemicals in human TK6 cells in the presence of rat liver S9
por: Yauk, Carole L., et al.
Publicado: (2016) -
Assessment of the performance of the TGx‐DDI biomarker to detect DNA damage‐inducing agents using quantitative RT‐PCR in TK6 cells
por: Cho, Eunnara, et al.
Publicado: (2018) -
Integrated Genotoxicity Testing of three anti-infective drugs using the TGx-DDI transcriptomic biomarker and high-throughput CometChip(®) assay in TK6 cells
por: Buick, Julie K., et al.
Publicado: (2022) -
TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals
por: Li, Heng-Hong, et al.
Publicado: (2019)